当前位置: X-MOL 学术World J. Stem Cells › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study.
World Journal of Stem Cells ( IF 4.1 ) Pub Date : 2021-6-18 , DOI: 10.4252/wjsc.v13.i5.470
Serdar Kabatas 1 , Erdinç Civelek 1 , Eyüp Can Savrunlu 1 , Necati Kaplan 2 , Osman Boyalı 1 , Furkan Diren 1 , Halil Can 3 , Ali Genç 4 , Tunç Akkoç 5 , Erdal Karaöz 6
Affiliation  

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of death and long-term neurological impairment in the pediatric population. Despite a limited number of treatments to cure HIE, stem cell therapies appear to be a potential treatment option for brain injury resulting from HIE.

中文翻译:

异基因间充质干细胞治疗小儿缺氧缺血性脑病的可行性:I 期研究。

缺氧缺血性脑病 (HIE) 是导致儿童死亡和长期神经功能障碍的主要原因之一。尽管治愈 HIE 的治疗方法数量有限,但干细胞疗法似乎是 HIE 导致的脑损伤的潜在治疗选择。
更新日期:2021-06-23
down
wechat
bug